What does an elevated serum creatinine of 1.87 mg/dL with a normal blood urea nitrogen indicate, and how should it be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Elevated Creatinine with Normal BUN: Evaluation and Management

An elevated serum creatinine of 1.87 mg/dL with normal BUN most likely indicates intrinsic kidney disease rather than prerenal azotemia, and requires immediate calculation of estimated GFR, urinalysis with albumin-to-creatinine ratio, and assessment for chronic versus acute kidney injury. 1, 2

Understanding the BUN/Creatinine Ratio

The normal BUN/creatinine ratio is 10-15:1. 3, 4 When creatinine is elevated (1.87 mg/dL) but BUN remains normal, this produces a low BUN/creatinine ratio (<10:1), which is distinctly different from the prerenal pattern. 1, 2

  • A BUN/creatinine ratio >20:1 typically indicates prerenal azotemia from volume depletion, heart failure, or reduced renal perfusion 1, 2
  • Your patient's normal BUN with elevated creatinine suggests intrinsic kidney disease affecting creatinine clearance more than urea handling 3

Immediate Diagnostic Steps

Calculate Estimated GFR

You must immediately calculate eGFR using the CKD-EPI equation (accounting for age, sex, and race), as serum creatinine alone is unreliable, especially in elderly patients with low muscle mass. 1, 2

  • eGFR ≥60 mL/min/1.73 m²: mild dysfunction or normal 2
  • eGFR 30-59 mL/min/1.73 m²: stage 3 CKD 2
  • eGFR 15-29 mL/min/1.73 m²: stage 4 CKD 2
  • eGFR <15 mL/min/1.73 m²: stage 5 CKD 2

Determine Acuity: AKI vs CKD

Compare this creatinine to baseline values within the past 3 months. 5, 2

Acute Kidney Injury (AKI) is defined by: 5, 2

  • ≥0.3 mg/dL increase within 48 hours, OR
  • ≥50% increase from baseline within 7 days, OR
  • Urine output <0.5 mL/kg/h for 6 hours

Chronic Kidney Disease (CKD) is defined by: 2

  • Creatinine ≥1.5 mg/dL in men or ≥1.3 mg/dL in women with eGFR <60 mL/min/1.73 m² persisting >3 months

Essential Laboratory Tests

Obtain the following within 48-72 hours: 1, 2

  • Urinalysis with microscopy to assess for proteinuria, hematuria, or abnormal sediment 1, 2
  • Urine albumin-to-creatinine ratio (UACR): ≥30 mg/g indicates kidney damage 2
  • Serum electrolytes and potassium 1
  • Repeat creatinine to confirm elevation and assess trajectory 2

Exclude Prerenal and Postrenal Causes

Despite the normal BUN, you should still assess for:

Prerenal factors: 1

  • Orthostatic hypotension
  • Decreased skin turgor and dry mucous membranes
  • Reduced urine output
  • Signs of heart failure (elevated JVP, peripheral edema, pulmonary crackles)

Postrenal obstruction: 1

  • Renal ultrasound if hydronephrosis is suspected

Medication Review

Review all medications for nephrotoxins: 6, 7

  • NSAIDs (discontinue immediately) 5
  • Aminoglycosides, vancomycin
  • Iodinated contrast exposure
  • ACE inhibitors/ARBs (see below for management)

ACE Inhibitor/ARB Management

If the patient is on ACE inhibitors or ARBs, creatinine increases up to 30% or <3.0 mg/dL are acceptable and represent hemodynamic changes rather than true kidney injury. 6, 1, 2 Do not discontinue these medications unless:

  • Creatinine increases >30% from baseline 6, 2
  • Absolute creatinine >3.0 mg/dL with acute rise ≥0.3 mg/dL 2
  • Concurrent volume depletion or hyperkalemia is present 6

Monitor serum potassium closely, as hyperkalemia risk increases progressively when creatinine exceeds 1.6 mg/dL. 1

Monitoring Strategy

For suspected CKD, monitor serum creatinine, electrolytes, and eGFR every 2-3 months initially. 1

Target blood pressure <140/90 mmHg (ideally <130/85 mmHg in patients with renal disease) to slow progression. 1

If UACR ≥30 mg/g is documented on at least two of three samples over 6 months, initiate ACE inhibitor or ARB therapy titrated to maximum tolerated doses. 7, 8

Nephrology Referral Criteria

Immediate nephrology referral is indicated if: 1, 2, 9

  • eGFR <30 mL/min/1.73 m² 1, 2
  • Significant proteinuria or hematuria 1
  • Abnormal urinary sediment 1
  • Rapidly progressive kidney disease (creatinine rising >0.5 mg/dL over weeks) 1
  • Uncertain etiology after initial workup 1, 9

All patients with newly discovered renal insufficiency (creatinine above the upper limit of normal) must undergo investigations to determine reversibility, evaluate prognosis, and optimize care planning. 9

Common Pitfalls

Do not assume prerenal azotemia based solely on clinical assessment. The normal BUN with elevated creatinine argues against simple volume depletion. 1, 3

Do not discontinue ACE inhibitors/ARBs prematurely. Small creatinine elevations up to 30% are expected and beneficial, not harmful. 6, 2

Do not delay nephrology referral. Adequate preparation for dialysis or transplantation requires at least 12 months of contact with a renal care team. 9

Exclude laboratory interference. Rarely, certain substances (like sarcosine in sarcosinemia) can cause falsely elevated creatinine on dry chemical enzyme tests. 10 If clinical picture doesn't match, confirm with a different assay method.

References

Guideline

Assessment of Renal Function in Patients with Elevated BUN and Creatinine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Elevated Creatinine: Clinical Significance and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Blood urea nitrogen and creatinine.

Emergency medicine clinics of North America, 1986

Guideline

(11) children and adolescents.

Diabetes Care, 2015

Research

Elevated levels of serum creatinine: recommendations for management and referral.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1999

Research

[Elevated serum creatinine without discernible kidney disease].

Deutsche medizinische Wochenschrift (1946), 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.